FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for ENVARSUS XR (tacrolimus extended-release) submitted by Veloxis Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• Envarsus XR (Tacrolimus)

Snippet

SUPPL AP for ENVARSUS XR (TACROLIMUS)